New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
11:20 EDTRMTI, RMTI, AFFY, AFFY, KERX, KERX, AMAG, AMAGSummer Street's biotech research team holds analyst/industry conference call
Biotech Analyst Research Team, along with an MCRI consultant, discuss dialysis and iron products for end-state renal disorders on an Analyst/Industry conference call to be held on January 31 at 11:30 am.
News For RMTI;AFFY;KERX;AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
11:23 EDTRMTIRockwell Medical volatility elevated into PDUFA
Subscribe for More Information
08:56 EDTRMTIFDA PDUFA Date for Rockwell Medical's Triferic is January 24, 2015
08:35 EDTRMTIRockwell Medical a buy ahead of PDUFA tomorrow, says Summer Street
Summer Street says it would be a buyer of Rockwell Medical shares ahead of tomorrow's FDA action date for Triferic. The firm sees an "excellent" chance of approval and believes Rockwell could be well into labeling discussions with the FDA. It has a Buy rating on the stock with a $25 price target.
January 21, 2015
19:55 EDTKERXKeryx 9.17M share Secondary priced at $12.00
The deal size was raised to 9.17M shares from 7.2M shares. JPMorgan acted as sole book running manager for the offering.
06:15 EDTRMTIRockwell Medical February volatility elevated into PDUFA
Rockwell Medical February call option implied volatility is at 132, March is at 101, May is at 96; compared to its 26-week average of 9- according to Track Data, suggesting large price movement into PDUFA Date for Triferic on January 24.
January 20, 2015
18:30 EDTKERXOn The Fly: After Hours Movers
Subscribe for More Information
16:06 EDTKERXKeryx files to sell $100M in common stock
J.P. Morgan is acting as the sole book-running manager in the offering. Keryx intends to use the net proceeds from the sale of its common stock to fund the ongoing commercialization and development of Auryxia in the US, pre-commercial activities in Europe, to potentially in-license, acquire and develop additional drug candidates, and other general corporate purposes.
January 14, 2015
07:37 EDTAMAGJPMorgan to hold a conference
Subscribe for More Information
January 12, 2015
05:12 EDTKERXKeryx names COO Greg Madison as CEO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use